Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 1
1946 1
1948 1
1949 3
1950 1
1955 1
1957 1
1960 1
1961 1
1962 1
1963 2
1964 2
1965 1
1966 3
1967 4
1968 9
1969 3
1970 11
1971 4
1972 3
1973 2
1974 3
1975 4
1976 7
1977 2
1978 2
1979 1
1981 3
1982 3
1983 3
1984 2
1985 6
1986 4
1987 7
1988 3
1989 7
1990 5
1991 4
1992 4
1993 8
1994 3
1995 9
1996 4
1997 7
1998 3
2000 1
2001 3
2002 2
2003 1
2004 1
2005 1
2006 2
2008 3
2009 3
2010 8
2011 4
2012 5
2013 3
2014 7
2015 6
2016 2
2017 2
2018 4
2019 10
2020 8
2021 6
2022 8
2023 6
2024 13
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

253 results

Results by year

Filters applied: . Clear all
Page 1
Impact of COVID-19 infection on lung function and nutritional status amongst individuals with cystic fibrosis: A global cohort study.
Semenchuk J, Naito Y, Charman SC, Carr SB, Cheng SY, Marshall BC, Faro A, Elbert A, Gutierrez HH, Goss CH, Karadag B, Burgel PR, Colombo C, Salvatore M, Padoan R, Daneau G, Harutyunyan S, Kashirskaya N, Kirwan L, Middleton PG, Ruseckaite R, de Monestrol I, Naehrlich L, Mondejar-Lopez P, Jung A, van Rens J, Bakkeheim E, Orenti A, Zomer-van Ommen D, da Silva-Filho LVR, Fernandes FF, Zampoli M, Stephenson AL; Global CF Registry Collaboration. Semenchuk J, et al. J Cyst Fibros. 2024 Sep;23(5):815-822. doi: 10.1016/j.jcf.2024.07.019. Epub 2024 Aug 26. J Cyst Fibros. 2024. PMID: 39191560 Free article.
[Erytropoietin].
OLESEN H. OLESEN H. Nord Med. 1962 Jul 12;68:883-8. Nord Med. 1962. PMID: 14481739 Danish. No abstract available.
IOL power mislabelling.
Olsen T, Olesen H. Olsen T, et al. Among authors: olesen h. Acta Ophthalmol (Copenh). 1993 Feb;71(1):99-102. doi: 10.1111/j.1755-3768.1993.tb04969.x. Acta Ophthalmol (Copenh). 1993. PMID: 8475722
Nanobody-mediated complement activation to kill HIV-infected cells.
Pedersen ML, Pedersen DV, Winkler MBL, Olesen HG, Søgaard OS, Østergaard L, Laursen NS, Rahimic AHF, Tolstrup M. Pedersen ML, et al. Among authors: olesen hg. EMBO Mol Med. 2023 Apr 11;15(4):e16422. doi: 10.15252/emmm.202216422. Epub 2023 Feb 17. EMBO Mol Med. 2023. PMID: 36799046 Free PMC article.
Close monitoring and early intervention: management principles for cystic fibrosis in Denmark.
Qvist T, Nielsen BU, Olesen HV, Mathiesen IHM, Faurholt-Jepsen D, Katzenstein TL, Helweg-Larsen J, Rönsholt F, Jeppesen M, Olsen MF, Buchvald FF, Nielsen KG, Jensen-Fangel S, Pressler T, Skov M. Qvist T, et al. Among authors: olesen hv. APMIS. 2024 Apr;132(4):223-235. doi: 10.1111/apm.13375. Epub 2024 Jan 24. APMIS. 2024. PMID: 38267398 Review.
Decline in HbA1c during the first year of elexacaftor/tezacaftor/ivacaftor treatment in the Danish cystic fibrosis cohort: Short title: Decline in HbA1c after elexacaftor/tezacaftor/ivacaftor treatment.
Nielsen BU, Olsen MF, Mabuza Mathiesen IH, Pressler T, Ritz C, Katzenstein TL, Olesen HV, Skov M, Jensen-Fangel S, Almdal TP, Faurholt-Jepsen D. Nielsen BU, et al. Among authors: olesen hv. J Cyst Fibros. 2024 Jan;23(1):103-108. doi: 10.1016/j.jcf.2023.11.005. Epub 2023 Nov 21. J Cyst Fibros. 2024. PMID: 37989700 Free article.
Report of the European Respiratory Society/European Cystic Fibrosis Society task force on the care of adults with cystic fibrosis.
Elborn JS, Bell SC, Madge SL, Burgel PR, Castellani C, Conway S, De Rijcke K, Dembski B, Drevinek P, Heijerman HG, Innes JA, Lindblad A, Marshall B, Olesen HV, Reimann AL, Solé A, Viviani L, Wagner TO, Welte T, Blasi F. Elborn JS, et al. Among authors: olesen hv. Eur Respir J. 2016 Feb;47(2):420-8. doi: 10.1183/13993003.00592-2015. Epub 2015 Oct 9. Eur Respir J. 2016. PMID: 26453627 Free article.
Real-world data confirm elexacftor/tezacaftor/ivacaftor modulators halves sweat chloride concentration in eligible people with cystic fibrosis.
Bryrup T, Faurholt-Jepsen D, Pressler T, Henriksen EH, Leo-Hansen C, Nielsen BU, Højte C, Mathiesen IHM, Katzenstein TL, Jeppesen M, Jensen-Fangel S, Olesen HV, Skov M, Qvist T, Olsen MF; TransformCF Study Group. Bryrup T, et al. Among authors: olesen hv. APMIS. 2024 Oct;132(10):728-733. doi: 10.1111/apm.13453. Epub 2024 Aug 2. APMIS. 2024. PMID: 39092470
253 results